IronNet (IRNTQ) 10-Q/A 2 May 22 2021 Q3 Quarterly report (amended) Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2021	Dec. 15, 2021
Document Information [Line Items]
Document Type	10-Q/A
Document Quarterly Report	true
Document Fiscal Year Focus	2021
Document Period End Date	Oct. 31, 2021
Document Transition Report	false
Entity File Number	001-39125
Amendment Flag	true
Amendment Description	On April 22, 2022, the Audit Committee of the Board of Directors (the “Audit Committee”) of the Company determined, based on the analysis and recommendation of management, that the Company’s unaudited consolidated financial statements and related disclosures included in the Form 10-Q should no longer be relied upon due to an error. The error was the result of the Company not appropriately applying modification accounting to stock-based compensation awards that were issued and outstanding as of August 26, 2021, the closing date of the merger between the Company and IronNet Cybersecurity, Inc. (“Legacy IronNet”). This overstatement relates to stock-based compensation expense for certain of the Company’s outstanding restricted stock units (“RSUs”) granted pursuant to Legacy IronNet’s 2014 Stock Incentive Plan.When calculating the additional stock-based compensation cost to recognize for modified unvested awards for the three months ended October 31, 2021, the Company considered requisite service rendered by the employee to start from the original vesting commencement date of the award. Upon further evaluation, the Company determined that the correct expense recognition applicable under Accounting Standards Codification Topic 718, Stock Compensation for a Type III (improbable-to-probable) modification requires the use of a method that utilizes the date of modification (August 26, 2021) as the beginning of the requisite service period for unvested portions of the awards outstanding, rather than the original vesting commencement date of the award. The impact of correcting the requisite service period start date is to shift the recognition of stock-based compensation expense to later periods.In connection with the restatement, the Company has also corrected previously identified immaterial errors. Refer to Note 2, “Restatement of Condensed Consolidated Financial Statements” of Notes to Unaudited Condensed Consolidated Financial Statements of this Form 10-Q/A for additional information. A summary of the accounting impacts of these errors to the Company’s unaudited condensed consolidated financial statements and related disclosures as of October 31, 2021 and for the three and nine months then ended is provided in Note 2, “Restatement of Condensed Consolidated Financial Statements,” of Notes to Unaudited Condensed Consolidated Financial Statements of this Form 10-Q/A.In connection with the restatement, the Company’s management determined that an additional material weakness existed in the Company’s internal control over financial reporting. See additional discussion included in Part I, Item 4 of this Amended Report.
Entity Incorporation, State or Country Code	DE
Entity Registrant Name	IronNet, Inc.
Entity Tax Identification Number	83-4599446
Entity Address, Address Line One	7900 Tysons One Place
Entity Address, Address Line Two	Suite 400
Entity Address, City or Town	McLean
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22102
Entity Central Index Key	0001777946
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
City Area Code	443
Local Phone Number	300-6761
Entity Common Stock, Shares Outstanding		88,718,630
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	IRNT
Security Exchange Name	NYSE
Warrants [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase common stock
Trading Symbol	IRNT.WS
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Current assets
Cash and cash equivalents	$ 73,891	$ 31,543
Accounts receivable	4,675	1,643
Unbilled receivable	5,064	1,425
Related party receivables and loan receivables	4,092	3,599
Account and loan receivables	13,831	6,667
Inventory	2,672	2,180
Deferred costs	2,416	2,068
Prepaid warranty	814	1,037
Prepaid expenses and other current assets	4,254	2,172
Total current assets	97,878	45,667
Deferred costs	1,320	2,056
Property and equipment, net	5,596	2,792
Prepaid warranty	897	878
Deposits and other assets	490	298
Total assets	106,181	51,691
Current liabilities:
Accounts payable	4,380	1,922
Accrued expenses	6,196	2,591
Deferred revenue	16,379	12,481
Deferred rent	154	134
Short-term PPP loan		3,487
Income tax payable	135	88
Other current liabilities	689	689
Total current liabilities	27,933	21,392
Deferred rent	808	928
Deferred revenue	17,910	21,563
Warrants	43
Long-term PPP loan		2,093
Other long-term liabilities payable	689	689
Total liabilities	47,383	46,665
Commitments and contingencies (Note 8)
Stockholders' equity
Preferred stock, $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding
Class A common stock; $0.0001 par value; 500,000,000 shares authorized; 88,718,630 and 65,353,098 shares issued and outstanding at October 31, 2021 and January 31, 2021, respectively	9	7
Additional paid-in capital	429,176	180,853
Accumulated other comprehensive (loss) income	268	40
Accumulated deficit	(370,655)	(175,039)
Subscription notes receivable		(835)
Total stockholders' equity	58,798	5,026
Total liabilities and stockholders' equity	$ 106,181	$ 51,691

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Oct. 31, 2021	Jan. 31, 2021
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares outstanding	88,718,630
Class A Common Stock
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	88,718,630	65,353,098
Common stock, shares outstanding	88,718,630	65,353,098

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Total revenue	$ 6,913	$ 7,013	$ 19,365	$ 21,826
Total cost of revenue	2,368	2,069	6,122	5,130
Gross Profit	4,545	4,944	13,243	16,696
Operating expenses
Research and development	24,455	5,687	38,917	19,965
Sales and marketing	51,244	7,155	66,095	23,265
General and administrative	79,735	4,715	91,419	16,690
Total operating expenses	155,434	17,557	196,431	59,920
Operating loss	(150,889)	(12,613)	(183,188)	(43,224)
Other (expense) income, net	(724)	178	(1,070)	125
Change in fair value of warrant liabilities	(11,302)		(11,302)
Loss before income taxes	(162,915)	(12,435)	(195,560)	(43,099)
Benefit (provision) for income taxes	(34)	(19)	(56)	(58)
Net income (loss)	$ (162,949)	$ (12,454)	$ (195,616)	$ (43,157)
Basic and diluted net loss per common share	$ (1.87)	$ (0.19)	$ (2.64)	$ (0.67)
Weighted average shares outstanding, basic and diluted	87,178,432	65,067,942	74,001,217	64,064,424
Product, Subscription and Support Revenue [Member]
Total revenue	$ 6,132	$ 5,958	$ 18,038	$ 18,047
Total cost of revenue	2,082	1,252	5,505	3,534
Professional Services Revenue [Member]
Total revenue	781	1,055	1,327	3,779
Total cost of revenue	$ 286	$ 817	$ 617	$ 1,596

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (162,949)	$ (12,454)	$ (195,616)	$ (43,157)
Change in net unrealized gains (losses) on available for sale investments, net of tax		(397)		(398)
Foreign currency translations adjustment, net of tax	303	(54)	228	(4)
Comprehensive loss	$ (162,646)	$ (12,905)	$ (195,388)	$ (43,559)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Public Warrants [Member]	Private Warrants [Member]	Additional Paid-in Capital	Additional Paid-in CapitalPublic Warrants [Member]	Additional Paid-in CapitalPrivate Warrants [Member]	(Accumulated Deficit)/ Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Subscription Notes Receivables	Previously Reported	Previously ReportedCommon Stock	Previously ReportedAdditional Paid-in Capital	Previously Reported(Accumulated Deficit)/ Retained Earnings	Previously ReportedAccumulated Other Comprehensive Income (Loss)	Previously ReportedSubscription Notes Receivables	Retroactive application of recapitalization	Retroactive application of recapitalizationCommon Stock	Retroactive application of recapitalizationAdditional Paid-in Capital	Series A Preferred StockPreviously ReportedPreferred Stock [Member]	Series A Preferred StockRetroactive application of recapitalizationPreferred Stock [Member]	Series B Preferred StockPreviously ReportedPreferred Stock [Member]	Series B Preferred StockRetroactive application of recapitalizationPreferred Stock [Member]	Class A Common StockCommon Stock	Class A Common StockCommon StockPublic Warrants [Member]	Class A Common StockCommon StockPrivate Warrants [Member]	Class A Common StockPreviously ReportedCommon Stock	Class A Common StockRetroactive application of recapitalizationCommon Stock	Class B Common StockPreviously ReportedCommon Stock	Class B Common StockRetroactive application of recapitalizationCommon Stock	Earnout Shares [Member]Common Stock
Beginning Balance at Jan. 31, 2020	$ 3,069			$ 123,235				$ 394	$ (900)	$ (118,125)		$ 2,041	$ (119,666)	$ 394	$ (900)	$ 121,194		$ 121,194	$ 32,500	$ (32,500)	$ 88,711	$ (88,711)	$ 6			$ 4	$ 2	$ 2	$ (2)
Beginning Balance (in Shares) at Jan. 31, 2020											17,607,000						(17,607,000)		794	(794)	1,217	(1,217)	60,122,000			36,138	23,984,000
Issuance of common stock	44,080			44,079																			$ 1
Issuance of common stock (in Shares)																							5,231,000
Interest earned on subscription notes receivable	12			12					(12)
Settlement of related party loan receivable for common shares	0
Payments on subscription notes receivable	47								47
Stock-based compensation	27			27
Unrealized gain(loss) on investments	(398)							(398)
Net Income (Loss)	(43,157)						$ (43,157)
Foreign currency translation adjustment, net of tax of $0	(4)							(4)
Ending Balance at Oct. 31, 2020	3,664			167,353			(162,823)	(8)	(865)														$ 7
Ending Balance (in Shares) at Oct. 31, 2020																							65,353,000
Beginning Balance at Jul. 31, 2020	14,104			164,929			(150,369)	443	(905)														$ 6
Beginning Balance (in Shares) at Jul. 31, 2020																							64,818,000
Issuance of common stock	2,450			2,449																			$ 1
Issuance of common stock (in Shares)																							535,000
Interest earned on subscription notes receivable				4					(4)
Payments on subscription notes receivable	44								44
Stock-based compensation	(29)			(29)
Unrealized gain(loss) on investments	(397)							(397)
Net Income (Loss)	(12,454)						(12,454)
Foreign currency translation adjustment, net of tax of $0	(54)							(54)
Ending Balance at Oct. 31, 2020	3,664			167,353			(162,823)	(8)	(865)														$ 7
Ending Balance (in Shares) at Oct. 31, 2020																							65,353,000
Beginning Balance at Jan. 31, 2021	5,026			180,853			(175,039)	40	(835)														$ 7
Beginning Balance (in Shares) at Jan. 31, 2021																							66,934,000
Issuance of common stock	305	$ 330	$ 21,492	305	$ 330	$ 21,492
Issuance of earnout (in Shares)																							1,078,000
Issuance of common stock (in Shares)																							598,000	29,000	3,188,000
Merger recapitalization	(12,026)			(12,027)																			$ 1
Merger recapitalization (in Shares)																							4,555,000
PIPE Shares	109,858			109,857																			$ 1
PIPE Shares (in Shares)																							12,500,000
Interest earned on subscription notes receivable	8			8					(8)
Settlement of related party loan receivable for common shares	(1,075)			(1,075)
Settlement of related party loan receivable for common shares (in Shares)																							108,000
Shares repurchase related to payment of subscription notes receivables	293			(550)					843
Shares repurchase related to payment of subscription notes receivables (in Shares)																							55,000
Stock-based compensation	129,983			129,983
Net Income (Loss)	(195,616)						(195,616)
Foreign currency translation adjustment, net of tax of $0	228							228
Ending Balance at Oct. 31, 2021	58,798			429,176			(370,655)	268															$ 9
Ending Balance (in Shares) at Oct. 31, 2021																							88,719,000
Beginning Balance at Jul. 31, 2021	(27,101)			181,181			(207,706)	(35)	(548)														$ 7
Beginning Balance (in Shares) at Jul. 31, 2021																							67,502,000
Issuance of common stock	10	$ 330	$ 21,492	10	$ 330	$ 21,492
Issuance of earnout (in Shares)																														1,078,000
Issuance of common stock (in Shares)																							30,000	29,000	3,188,000
Merger recapitalization	(12,026)			(12,027)																			$ 1
Merger recapitalization (in Shares)																							4,555,000
PIPE Shares	109,858			109,857																			$ 1
PIPE Shares (in Shares)																							12,500,000
Interest earned on subscription notes receivable				2					(2)
Settlement of related party loan receivable for common shares	(1,075)			(1,075)
Settlement of related party loan receivable for common shares (in Shares)																							108,000
Shares repurchase related to payment of subscription notes receivables				(550)					$ 550
Shares repurchase related to payment of subscription notes receivables (in Shares)																							55,000
Stock-based compensation	129,956			129,956
Net Income (Loss)	(162,949)						(162,949)
Foreign currency translation adjustment, net of tax of $0	303							303
Ending Balance at Oct. 31, 2021	$ 58,798			$ 429,176			$ (370,655)	$ 268															$ 9
Ending Balance (in Shares) at Oct. 31, 2021																							88,719,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) (Parenthetical) $ in Thousands	Jan. 31, 2020	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)
Statement of Stockholders' Equity [Abstract]
Other comprehensive income loss foregin currency translation adjustment net of tax		$ 0	$ 0	$ 0	$ 0
Series A and Series B preferred stock conversion to class A common stock	0.1
Class B common stock conversion to class A common stock	1
Exchange ratio	0.8141070

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Cash flows from operating activities
Net loss	$ (195,616)	$ (43,157)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	659	935
Loss (Gain) on sale of fixed assets	1	(220)
Bad debt expense	0	33
Employee stock based compensation	129,983	27
Non-cash interest expense	1,061	97
Change in fair value of warrants liabilities	11,302
Non-cash interest income on amounts due from stockholder	8	12
Changes in operating assets and liabilities:
Accounts receivable	7,163	962
Deferred costs	388	(982)
Inventory	492	494
Prepaid expenses and other current assets	3,157	71
Deposits and other assets	194	(75)
Prepaid warranty	(205)	(157)
Accounts payable	1,151	(976)
Accrued expenses	2,552	1,388
Income taxes payable	47	58
Deferred rent	(100)	(131)
Deferred revenue	(245)	2,689
Warrants	43	0
Other long-term liabilities payable	0	1,209
Net cash used in operating activities	(59,095)	(39,897)
Cash Flows from Investing Activities:
Purchases of property and equipment	(2,385)	(425)
Proceeds from the sale of fixed assets	228	81
Sales of investments	0	647
Proceeds from the maturity of investments	0	754
Net cash provided by investing activities	(2,156)	1,057
Cash Flows from Financing Activities:
Proceeds from issuance of common stock	634	44,080
Proceed from borrowing SVB Bridge loan	15,000	0
Proceeds from borrowing of PPP loan	0	5,580
Payment of loan - SVB bridge	15,000	0
Payment of PPP loan	5,580
Merger recapitalization	4,214
Proceeds from PIPE shares	125,000
Payment of transaction costs	(21,179)	0
Proceeds from stock subscriptions	292	47
Net cash provided by financing activities	103,381	49,707
Effect of exchange rate changes on cash and cash equivalents	218	(407)
Net change in cash and cash equivalents	42,348	10,460
Cash and Cash Equivalents
Beginning of the period	31,543	10,806
End of the period	73,891	21,266
Supplemental disclosure of non-cash activities:
Interest earned on subscription notes receivable	8	12
Unpaid purchases of property and equipment	(1,306)	0
Non-cash settlement of related party loan receivable for common shares	(1,075)	0
Unrealized loss on investment	$ 0	$ (2)

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Organization and Summary of Significant Accounting Policies	1. Organization and Summary of Significant Accounting Policies IronNet, Inc. (hereinafter “IronNet”, “we”, “us”, “our”, or “the Company”), through IronNet Cybersecurity, Inc. (“Legacy IronNet”) and its subsidiaries (collectively “Combined Company”), provides a suite of technologies that provide real-time threat assessment and updates, behavioral modeling, big data analytics, and proactive threat detection and response capabilities as well as consulting services and training programs to protect against current and emerging cyber-threats. The Company, whose securities are listed on the New York Stock Exchange (“NYSE”), serves as the holding company for the businesses of Legacy IronNet and its subsidiaries. Its headquarters are located in McLean, VA. Legacy IronNet was incorporated in the state of Delaware on April 30, 2019. Merger Agreement On August 26, 2021, LGL Systems Acquisition Corp. ("Legacy LGL”), through its subsidiary LGL Systems Merger Sub Inc. (“Merger Sub”) and Legacy IronNet, all of them Delaware corporations, consummated the closing of the transactions contemplated by the Merger Agreement, dated March 15, 2021 and as amended August 6, 2021, by and among Legacy IronNet, Legacy LGL, and Merger Sub, following their approval at a special meeting of the stockholders of Legacy LGL held on August 26, 2021 (the “Merger”). Pursuant to the terms of the Merger Agreement, a merger of Legacy IronNet and Legacy LGL was effected by the merger of Merger Sub with and into Legacy IronNet, with Legacy IronNet surviving the Merger as a wholly-owned subsidiary of Legacy LGL. Following the consummation of the Merger, Legacy LGL changed its name from LGL Systems Acquisition Corp. to IronNet, Inc. on the closing date. Pursuant to the Merger Agreement, at the effective time of the Merger, (i) each outstanding share of Legacy IronNet common stock and preferred stock (with each share of Legacy IronNet preferred stock being treated as if it were converted into ten (10) shares of Legacy IronNet common stock on the effective date of the Merger) was converted into the right to receive (a) a number of shares of Company common stock equal to the Exchange Ratio (as defined below) and (b) a cash amount payable in respect of fractional shares of Legacy IronNet common stock that would otherwise be issued in connection with the foregoing conversion, if applicable, and (ii) each Legacy IronNet option, restricted stock unit, restricted stock award that was outstanding immediately prior to the closing of the Merger (and by its terms did not terminate upon the closing of the Merger) remains outstanding and (x) in the case of options, represents the right to purchase a number of shares of Company common stock equal to the number of shares of Legacy IronNet common stock subject to such option multiplied by the Exchange Ratio used for Legacy IronNet common stock (rounded down to the nearest whole share) at an exercise price per share equal to the current exercise price per share for such option divided by the Exchange Ratio (rounded up to the nearest whole cent) and (y) in the case of restricted stock units and restricted stock awards, represent a number of shares of Company common stock equal to the number of shares of Legacy IronNet common stock subject to such restricted stock unit or restricted stock award multiplied by the Exchange Ratio (rounded down to the nearest whole share). In addition, Legacy IronNet stockholders and eligible holders of options, restricted stock unit awards and restricted stock awards (as applicable, only to the extent time vested as of the closing of the Merger) were also eligible to receive additional merger consideration in the form of a pro rata portion of 1,078 s hares of Company common stock if the volume weighted average closing share price for the Company’s common stock equaled or exceeded $ 13.00 for ten ( 10 ) consecutive days during the two-year period following the closing of the Merger. This condition was satisfied and the additional shares of Company common stock were issued in September 2021. The Exchange Ratio was 0.8141070 of a share of Company common stock per fully-diluted share of Legacy IronNet common stock. On August 26, 2021, the Company received $ 13,251 held in Legacy LGL’s trust account net of redemptions. Transaction costs related to the issuance of the trust shares were $ 9,038 . In connection with the execution of the Merger Agreement, a number of purchasers (each, a “Subscriber”) purchased from the Company an aggregate of 12,500,000 shares of Company common stock (the “PIPE Shares”), for a purchase price of $ 10.00 per share and an aggregate purchase price of $ 125,000 , pursuant to separate subscription agreements entered into effective as of March 15, 2021. Transaction costs related with the issuance were $ 21,180 . Basis of Presentation and Principles of Consolidation The unaudited interim condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. The Merger was accounted for as a reverse recapitalization in accordance with Accounting Standards Codification (“ASC”) 805, Business Combination. As a result of Legacy IronNet being the accounting acquirer in the Merger, the financial reports filed with the SEC by the Company subsequent to the Merger are prepared as if Legacy IronNet is the accounting predecessor of the Company. The historical operations of Legacy IronNet are deemed to be those of the Company. Thus, the financial statements included in this Amendment No 1. reflect (i) the historical operating results of Legacy IronNet prior to the Merger; (ii) the consolidated results of the Company, following the Merger on August 26, 2021; (iii) the assets and liabilities of Legacy IronNet at their historical cost; and (iv) the Company’s equity structure for all periods presented. The recapitalization of the number of shares of common stock is reflected retroactively to the earliest period presented and will be utilized for calculating loss per share in all prior periods presented. These unaudited interim condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements of Legacy IronNet, Inc. and accompanying notes thereto for the year ended January 31, 2021. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The Company’s fiscal year ends on January 31. References to fiscal 2022, for example, refer to the fiscal year ending January 31, 2022. The results of operations for the nine and three months ended October 31, 2021 are not necessarily indicative of the operating results that may be expected for the full fiscal year ending January 31, 2022 or any future period. The accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, except for the adjustments described as part of the Merger discussed in Note 3, necessary for a fair statement of the Company’s financial position as of October 31, 2021, its results of operations for the three and nine months ended October 31, 2021 and 2020, and cash flows for the nine months ended October 31, 2021 and 2020. Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results may differ from estimates under different assumptions or conditions. The Company recognized Public Warrants in equity at fair value as of the effective date of the Merger and recognized $ 15,740 in additional paid in capital. Warrants The Company accounts for the 8,606,473 warrants (comprised of 8,596,273 Public Warrants and 10,200 Private Warrants) in accordance with the guidance contained in ASC 815-40-15-7D. The Private Warrants do not meet the criteria for equity classification and they are recorded as liabilities. Accordingly, the Company classifies the warrant instruments as liabilities at their fair value and adjusts the instrument to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations. The fair value of the Private Warrants has been determined based on a Monte Carlo model. In connection with the Merger, the Public Warrants were recorded within equity at a fair value of $ 15,740 . The Public Warrants meet the criteria for equity classification and are recorded within Stockholders’ Equity. Accordingly, Public Warrants are initially measured at fair value and are not subject to re-measurement at each balance sheet date unless, in subsequent periods the Public Warrants no longer qualify for equity classification. The fair value of the Public Warrants issued by the Company has been determined using the quoted price. Recent Accounting Pronouncements not Yet Adopted The FASB issued ASU No.2016-02, Leases (Topic 842) (“ASU 2016-02”), which supersedes the current lease requirements in ASC 840, Leases . ASU 2016-02 requires lessees to recognize a right-of-use asset and related lease liability for all leases, with a limited exception for short-term leases. Leases will be classified as either finance or operating, with the classification affecting the pattern of expense recognition in the statement of operations. Currently, leases are classified as either capital or operating, with any capital leases recognized on the consolidated balance sheets. The reporting of lease-related expenses in the consolidated statements of operations and cash flows will be generally consistent with the current guidance. The new lease guidance will be effective the earlier of the year ending January 31, 2023 or the time at which we no longer qualify as an EGC (“Emerging Growth Company”) and will be applied using a modified retrospective transition method to either the beginning of the earliest period presented or the beginning of the year of adoption. The Company is currently evaluating the impact of adopting the new standard. The adoption of this standard will require the recognition of a right of use asset and liability on the Company’s consolidated balance sheets. In June 2016, the FASB issued ASU2016-13, Measurement of Credit Losses on Financial Instruments (Topic 326). This standard requires a new method for recognizing credit losses that is referred to as the current expected credit loss (“CECL”) method. The CECL method requires the recognition of all losses expected over the life of a financial instrument upon origination or purchase of the instrument, unless the Company elects to recognize such instruments at fair value with changes in profit and loss (the fair value option). This standard is effective for the Company for the earlier of the fiscal years beginning after December 15, 2022 or the time at which we no longer qualify as an EGC. Management is currently evaluating the potential impact of this guidance on its financial statements. New Accounting Pronouncement Adopted in Fiscal 2022 In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic740): Simplifying the Accounting for Income Taxes , which modifies and eliminates certain exceptions to the general principles of ASC 740, Income Taxes . ASU 2019-12 was adopted in the first quarter of fiscal 2022. The prospective adoption of ASU 2019-12 was not material. In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and of Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . ASU 2018-15 was adopted in the third quarter of fiscal 2022. The prospective adoption of ASU 2018-15 was not material. Segment and Geographic Information Segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”), in deciding how to allocate resources and assess performance. The CODM reviews financial information presented on a consolidated basis for the purposes of allocating resources and evaluating financial performance. Accordingly, management has determined that the Company operates as one operating segment. The following table presents revenue by geographic location: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 United States $ 6,226 $ 6,310 $ 17,210 $ 20,309 International 687 703 2,155 1,517 Total $ 6,913 $ 7,013 $ 19,365 $ 21,826 Substantially all of the Company’s long-lived assets are located in the United States.

Restatement of Condensed Consol

Restatement of Condensed Consolidated Financial Statements	9 Months Ended
	Oct. 31, 2021
Accounting Changes and Error Corrections [Abstract]
Restatement of Condensed Consolidated Financial Statements	2 . Restatement of Condensed Consolidated Financial Statements IronNet has restated its previously issued unaudited condensed consolidated interim financial statements and related disclosures as of and for the three and nine months ended October 31, 2021 included in its Original Form 10-Q (as defined below) filed with the Securities and Exchange Commission (the “SEC”) in order to correct errors resulting from the incorrect application of generally accepted accounting principles relating to the recognition of stock-based compensation expense as it pertains to restricted stock unit awards (“RSUs”) granted under the 2014 Stock Incentive Plan. Additionally, the Company is also correcting for other previously identified immaterial errors. The applicable Notes were also updated to reflect the restatement. Impact of Restatement . The impact of correcting the requisite service period is to shift the recognition of stock-based compensation expense to later periods. The Company determined that the correction to stock-based compensation decreased stock-based compensation expense, as disclosed in Note 6. Stock Incentive Plan, and net loss by approximately $ 30.2 million for the three and nine months ended October 31, 2021. 2.4 million, $ 1.2 million, $ 0.6 million, and $ 4.2 million for the respective account as of October 31, 2021. The Company was previously reporting receivable balances only to the extent that basic criteria for revenue recognition had already been satisfied, and was netting the receivable associated with deferred revenue against the corresponding deferred revenue balance. The Company has corrected the unaudited condensed consolidated financial statements to increase the receivables and corresponding deferred revenue for which it has the unconditional right to receive the consideration as of October 31, 2021. As of October 31, 2021 Balance Sheet As Previously Reported Adjustments As Restated Assets Current assets: Accounts receivable $ 2,246 $ 2,429 $ 4,675 Unbilled receivables 3,885 1,179 5,064 Related party receivables and loan receivables 3,521 571 4,092 Account and loan receivable 9,652 4,179 13,831 Total current assets 93,699 4,179 97,878 Total assets $ 102,002 $ 4,179 $ 106,181 Liabilities and stockholders' equity Current liabilities: Deferred Revenue $ 12,929 $ 3,450 $ 16,379 Total current liabilities 24,483 3,450 27,933 Deferred Revenue 17,181 729 17,910 Total liabilities $ 43,204 $ 4,179 $ 47,383 Stockholders' equity Additional paid-in capital $ 459,349 $ ( 30,173 ) $ 429,176 Accumulated deficit ( 400,828 ) 30,173 ( 370,655 ) Total liabilities and stockholders' equity $ 102,002 $ 4,179 $ 106,181 3 Months Ended October 31, 2021 9 Months Ended October 31, 2021 Statement of Operations As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Research and development $ 28,144 $ ( 3,689 ) $ 24,455 $ 42,606 $ ( 3,689 ) $ 38,917 Sales and marketing 57,196 ( 5,952 ) 51,244 72,046 ( 5,951 ) 66,095 General and administrative 100,267 ( 20,532 ) 79,735 111,952 ( 20,533 ) 91,419 Operating Expenses 185,607 ( 30,173 ) 155,434 226,604 ( 30,173 ) 196,432 Operating Loss ( 181,062 ) 30,173 ( 150,889 ) ( 213,361 ) 30,173 ( 183,188 ) Loss before income taxes ( 193,088 ) 30,173 ( 162,915 ) ( 225,733 ) 30,173 ( 195,560 ) Benefit (provision) for income taxes ( 34 ) - ( 34 ) ( 56 ) - ( 56 ) Net loss ( 193,122 ) 30,173 ( 162,949 ) ( 225,789 ) 30,173 ( 195,616 ) Basic and diluted net loss per common share $ ( 2.22 ) $ 0.35 $ ( 1.87 ) $ ( 3.05 ) $ 0.41 $ ( 2.64 ) 9 Months Ended October 31, 2021 Statement of Cash Flows As Previously Reported Adjustments As Restated Cash flows from operating activities Net Loss $ ( 225,789 ) $ 30,173 $ ( 195,616 ) Employee stock based compensation 160,156 ( 30,173 ) 129,983 Change in Operating Assets and Liabilities Accounts receivable ( 2,984 ) ( 4,179 ) ( 7,163 ) Deferred revenue ( 3,934 ) 4,179 245 Net cash used in operating activities $ ( 59,095 ) $ - $ ( 59,095 ) 3 Months Ended October 31, 2021 9 Months Ended October 31, 2021 Statements of Comprehensive Loss As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Net loss $ ( 193,122 ) $ 30,173 $ ( 162,949 ) $ ( 225,789 ) $ 30,173 $ ( 195,616 ) Comprehensive loss $ ( 192,819 ) $ 30,173 $ ( 162,646 ) $ ( 225,561 ) $ 30,173 $ ( 195,388 ) Statement of Changes in Stockholders' Equity for the 3 months Ended October 31, 2021 Additional Paid-In Capital Accumulated Deficit Total Stockholders' Equity As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Stock-based compensation $ 160,129 $ ( 30,173 ) $ 129,956 $ 160,129 $ ( 30,173 ) $ 129,956 Net loss ( 193,122 ) 30,173 ( 162,949 ) ( 193,122 ) 30,173 ( 162,949 ) Balance at October 31, 2021 $ 459,349 $ ( 30,173 ) $ 429,176 $ ( 400,828 ) $ 30,173 $ ( 370,655 ) $ 58,798 $ - $ 58,798 Statement of Changes in Stockholders' Equity for the 9 months Ended October 31, 2021 Additional Paid-In Capital Accumulated Deficit Total Stockholders' Equity As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Stock-based compensation $ 160,156 $ ( 30,173 ) $ 129,983 $ 160,156 $ ( 30,173 ) $ 129,983 Net loss ( 225,789 ) 30,173 ( 195,616 ) ( 225,789 ) 30,173 ( 195,616 ) Balance at October 31, 2021 $ 459,349 $ ( 30,173 ) $ 429,176 $ ( 400,828 ) $ 30,173 $ ( 370,655 ) $ 58,798 $ - $ 58,798

Reverse Recapitalization

Reverse Recapitalization	9 Months Ended
	Oct. 31, 2021
Business Combinations [Abstract]
Business Combination	3. Reverse Recapitalization On August 26, 2021, the Merger was accounted for as a reverse recapitalization under U.S. GAAP. Legacy IronNet was the accounting acquirer and Legacy LGL was the accounting acquiree for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of the Combined Company represent a continuation of the financial statements of Legacy IronNet, with the Merger being treated as the equivalent of Legacy IronNet issuing stock for the net assets of Legacy LGL, accompanied by a recapitalization. The net assets of Legacy LGL are stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of Legacy IronNet. The following table reconciles the elements of the Merger to the condensed consolidated statement of cash flows for the nine months ended October 31, 2021: Recapitalization and associated transactions Cash (Trust) $ 173,015 Redemptions ( 159,763 ) Less: fees to underwriters and advisors ( 9,038 ) Net cash received from Merger recapitalization 4,214 Issuance of PIPE Shares 125,000 Less: PIPE fees to underwriters and advisors ( 21,179 ) Net cash received from PIPE Shares and Merger recapitalization 108,035 Less: debt settlement ( 21,266 ) Net proceeds from Merger recapitalization, PIPE Shares and debt settlement $ 86,769 The number of outstanding shares of common stock of the Company as of October 31, 2021 is summarized as follows: Shares by Type Number of shares IronNet Class A Common Stock outstanding previous to the Merger 67,501,813 Issuance of common stock (exercises of ISOs and warrant) 28,734 Number of Shares issued at the date of the business combination ( Recapitalization) LGL Class A Common Stock outstanding previous to the Merger 17,250,000 Less: Redemption of LGL Class A previous to the Merger ( 15,928,889 ) Total Class A Shares issued to former LGL shareholders 1,321,111 LGL Founders Shares 3,234,375 PIPE Shares 12,500,000 Number of Share issued at the Merger 17,055,486 Number of Shares issued (redeemed) following the consummation of the Merger Earnout Shares 1,078,125 Private Warrants (Exercised) 3,188,229 Public Warrants (Exercised) 28,719 Payments on subscription notes receivable ( 54,955 ) Shares repurchase related to loan pay-off ( 107,521 ) Total Shares of Common Stock as of October 31, 2021 88,718,630 In connection with the closing of and as a result of the consummation of the Merger, certain members of the Company’s management and employees received bonus payments in the aggregate amount of $ 0.5 million. The bonuses have been reflected in general and administrative expenses in the condensed consolidated statements of operations. For the three and nine months ended October 31, 2021, the Company also incurred transaction costs related to the Merger of approximately $ 1,556 and $ 2,328 , respectively , which are included in general and administrative expenses on the condensed consolidated statement of operations. IronNet Class A Common Stock (Legacy IronNet Founders Shares) Pursuant to the Merger Agreement, at the effective time of the Merger each outstanding share of Legacy IronNet preferred shares and common stock were converted into Class A common stock based on the Exchange Ratio described in Note 1. PIPE Shares On August 26, 2021, a number of purchasers (each, a “Subscriber”) purchased from the Company an aggregate of 12,500,000 shares of Company common stock (the “PIPE Shares”), for a purchase price of $ 10.00 per share and an aggregate purchase price of $ 125,000 , pursuant to separate subscription agreements entered into effective as of March 15, 2021 (each, a “Subscription Agreement”). Pursuant to the Subscription Agreements, the Company granted certain registration rights to the Subscribers with respect to the PIPE Shares. The sale of the PIPE Shares was consummated concurrently with the closing of the Merger in an amount of $ 125,000 . Founders Shares Reflects 3,234,375 shares of Class A common stock (the “Founder Shares”) for an aggregate purchase price of $ 24 , or approximately $ 0.007 per share. Debt Settlements Loan and Security Agreement On June 21, 2021, Legacy IronNet entered into a Loan and Security Agreement (“Term Loan” or “SVB Bridge”) with SVB Innovation Credit Fund VIII, L.P. for term loan advances of up to $ 15,000 to provide for working capital needs over the period leading up to completion of the combination with Legacy LGL. The Term Loan was able to be prepaid at any time and had a term for up to six months, or until the date on which Legacy IronNet completed its combination with Legacy LGL, whichever came sooner, and bore monthly interest at a per annum rate equal to eight percent, as well as customary fees for de-SPAC bridge loans of this nature. As of August 26, 2021, in conjunction with the Merger, the Company repaid the term loan principal and accrued interest in an aggregate amount of $ 15,609 . PPP loan On April 21, 2020, Legacy IronNet entered into a Paycheck Protection Program (PPP) loan from the US Small Business Administration pursuant to the provision of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act, receiving loan funds of $ 5,580 . The loan bears interest at 1 % and is payable in monthly installments beginning on September 15, 2021 . As of October 31, 2021, and January 31, 2021, Legacy IronNet had an interest accrual of $ 0 and $ 44 related to the PPP loan. The unsecured loan was evidenced by a promissory note of the Company with PNC Bank (the “Lender”). On August 26, 2021, in conjunction with the Merger, the Company repaid in full all amounts due and terminated all commitments and obligations under the unsecured PPP loan. Loans to Employees On December 29, 2018, Legacy IronNet entered into a loan with a current executive of the Company with a principal balance of $ 1,000 bearing an interest rate of 2.76 % for a term of three years, which was secured by a pledge of certain shares of Legacy IronNet Class A common stock. As of August 26, 2021, in conjunction with the merger, the Company resolved the loan by having the executive surrender to the Company 107,521 shares that would have otherwise been issuable to the executive in the Merger. Earnout Pursuant to the terms of the Merger Agreement, the eligible Legacy IronNet Equityholders had the right to receive up to 1,078,125 Earnout Shares, issuable upon the occurrence of the Merger. As of the close of trading on September 10, 2021, the requisite conditions of the Earnout Triggering Event were satisfied and the Company issued 1,078,125 Earnout Shares to the eligible Equityholders. The earnout does not represent contingent consideration and is in accordance with ASC 815-40. The earnout shares were indexed to the Company’s own common stock and meet the requirements for equity classification. Restricted Stock Units (Restated) Under the terms of the Legacy IronNet’s restricted stock units, vesting of each award was subject to, among other conditions including a service requirement, the occurrence of a liquidity event, as defined by Legacy IronNet’s 2014 Stock Incentive Plan. On August 26, 2021, in connection with the close of the Merger with Legacy LGL, the Company’s Board of Directors resolved to deem the Merger as satisfying the Liquidity Event condition. The resolution resulted in a modification of the restricted stock unit awards under ASC 718 “ Compensation—Stock Compensation. ” As a consequence of modification of the awards outstanding, the Company recognized a non-cash expense in the fiscal third quarter 2022 in an amount of $ 129,921 related to 16,634,972 outstanding RSUs, with 8,204,455 remaining unvested as of October 31, 2021.

Revenue

Revenue	9 Months Ended
	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue	4. Revenue Software, subscription and support revenue The Company sells a collective defense software solution that provides a near real time collective defense infrastructure that is comprised of two product offerings, IronDefense and IronDome. The software platform is delivered through both on-premises licenses bundled with on-premises hardware and through subscription software. Our security appliance deliverables include proprietary operating system software and hardware, which together with regular threat intelligence updates and support, maintenance, and warranty. We combine intelligence dependent hardware and software licenses with the related threat intelligence and support and maintenance as a single performance obligation, as it delivers the essential functionality of our cybersecurity solution. As a result, we recognize revenue for this single performance obligation ratably over the expected term with the customer. Significant judgement is required for the assessment of material rights relating to renewal options associated with our contracts. Revenue from subscriptions, which allow customers to use our security software over a contracted period without taking possession of the software, and managed services, where we provide managed detection and response services for customers, are recognized over the contractual term. The cloud- based subscription revenue, where we also provide hosting, recognized for the three months ended October 31, 2021 and 2020 was $ 3,792 and $ 2,180 , respectively, and for the nine months ended October 31, 2021 and 2020, were $ 10,993 and $ 6,475 , respectively. Overall subscription revenue recognized for the three months ended October 31, 2021 and 2020, were $ 6,092 and $ 4,432 , respectively, and for the nine months ended October 31, 2021 and 2020 were $ 17,992 and $ 13,231 , respectively. Professional services revenue The Company sells professional services, including cyber operations monitoring, security, training and tailored maturity assessments. Revenue derived from these services is recognized as the services are delivered. Customer concentration For the nine months ended October 31, 2021, and 2020, two customers accounted for 22 %, or $ 4,283 , and one customer accounted for 10 %, or $ 2,174 , of the Company’s revenue, respectively. As of October, 2021, and January 31, 2021, three customers represent 60 % of the total accounts receivable, and as of January 31, 2021, three customers represented 85 % of the total accounts receivable balance. Significant customers are those which represent at least 10 % of the Company’s total revenue at each respective period ending date. The following table presents customers that represent 10% or more of the Company’s total revenue: For the Three Months Ended October 31, For the Nine Months Ended October 31, 2021 2020 2021 2020 Customer A 12 % * 11 % * Customer B 11 % 15 % 11 % * Customer C * * * 10 % 23 % 15 % 22 % 10 % * - less than 10 % Deferred Costs The Company defers contract fulfillment costs that include appliance hardware. The balances in deferred costs are as follows: Balance at February 1, 2021 $ 2,805 Cost of revenue recognized ( 1,033 ) Costs deferred 473 Foreign exchange ( 3 ) Balance at October 31, 2021 $ 2,242 Balance at February 1, 2020 3,080 Cost of revenue recognized ( 832 ) Costs deferred 711 Foreign exchange ( 3 ) Balance at October 31, 2020 $ 2,956 The balance of deferred commissions at October 31, 2021 and January 31, 2021 were $ 1,494 and $ 1,319 , respectively. Deferred commissions are included in the deferred costs on the condensed consolidated balance sheets, of which $ 1,061 is current and $ 433 is long-term as of October 31, 2021. Deferred revenue Deferred revenue represents amounts received from and/or billed to customers in excess of revenue recognized. Amounts that have been invoiced are recorded in accounts receivable and in deferred revenue or revenue depending on whether the revenue recognition criteria have been met. The balance in deferred revenue is as follows: (As Restated) Balance at February 1, 2021 $ 34,044 Revenue recognized ( 23,687 ) Revenue deferred 23,944 Foreign exchange ( 12 ) Balance at October 31, 2021 $ 34,289 Balance at February 1, 2020 20,312 Revenue recognized ( 19,507 ) Revenue deferred 22,196 Foreign exchange - Balance at October 31, 2020 $ 23,001 Remaining performance of deferred revenue (Restated) As of October 31, 2021, the remaining performance obligations in deferred revenue totaled $ 34,289 . The Company’s recognition of revenue in the future thereon will be as follows: Years Ending January 31, 2022 (3 months) $ 7,413 2023 12,477 2024 8,382 2025 4,466 2026 1,551 $ 34,289

Equity

Equity	9 Months Ended
	Oct. 31, 2021
Stockholders' Equity Note [Abstract]
Equity	5. Equity Common Stock As of October 31, 2021, the Company had 500,000,000 shares of Class A common stock authorized and 88,718,630 shares common stock issued and outstanding at $ 0.0001 par value per share. Each share of Common Stock has 1 vote. Preferred Stocks The Company is authorized to issue 100,000,000 shares of preferred stock with a par value of $ 0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At October 31, 2021, there were no shares of preferred stock issued or outstanding. Warrants Private Warrants Simultaneously with the closing of Legacy LGL’s Initial Public Offering, the sponsor purchased an aggregate of 5,200,000 Private Warrants at a price of $ 1.00 per Private Warrant, for an aggregate purchase price of $ 5,200 from Legacy LGL. Over the period of September 2021 through October 2021, when the majority of these warrants were exercised on a cashless basis, the formula for such exercises made each Private Warrant effectively exercisable to purchase approximately 0.6 s hares of Company common stock on a non-cash basis, each subject to its own exercise calculation applicable to the day on which the exercise was made. The Private Warrants were also redeemable in cash for $ 11.50 for a share of common stock. No Private Warrants were redeemed on the $ 11.50 cash basis. In September and October 2021, 5,189,800 Private Warrants were exercised on a cashless basis into 3,188,229 shares of Class A common stock. As of October 31, 2021, the Company had 10,200 Private Warrants outstanding and not exercised. During the period ended October 31, 2021, prior to the exercise of the Private warrants , the Company recognized in the interim condensed statements of operations $ 11,302 of non-cash expense related to change in fair value of warrants. Public Warrants Public Warrants may only be exercised for a whole number of shares at a price of $ 11.50 per share. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants became exercisable in September 2021. The Public Warrants will expire five years after the completion of the Merger or earlier upon redemption or liquidation. Once the warrants became exercisable upon the effective date of the Company’s S-1 registration statement, the Company obtained the ability to redeem the Public Warrants: • in whole and not in part; • at a price of $ 0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption; and • if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $ 18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the Warrant Agreement. In October, 28,719 Public Warrants were exercised in an amount of $ 330 and 28,719 shares were issued at a price of $ 11.50 . As of October 31, 2021, the Company had 8,596,273 Public Warrants outstanding and not exercised.

Stock Incentive Plan

Stock Incentive Plan	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock Incentive Plan	6. Stock Incentive Plan Legacy IronNet’s Board of Directors adopted and the stockholders approved Legacy IronNet’s 2014 Stock Incentive Plan (the “2014 Plan”) on September 29, 2014 and on October 17, 2014, respectively. The 2014 Plan was periodically amended, most recently on June 7, 2019. The 2014 Plan permitted the grant of incentive stock options “ISOs,” non-qualified stock options “NSOs,” stock appreciation rights, restricted stock, restricted stock units “RSUs,” and other stock-based awards. ISOs were only able to be granted to Legacy IronNet’s employees and to any of the employees of Legacy IronNet’s subsidiary corporations’ employees. All other awards could be granted to employees, directors and consultants of Legacy IronNet’s and to any of Legacy IronNet’s parent or subsidiary corporation’s employees or consultants. On August 26, 2021, the closing date of the Merger, per the Merger Agreement, the outstanding Legacy IronNet ISO and RSU grants issued under the 2014 Plan were converted to their post-transaction equivalents based on the conversion ratio, which total 18,971,549 shares in the Combined Company when exercised or converted. Additionally, as of the closing date, the 2021 Equity Incentive Plan (the “2021 Plan”) was approved by Legacy LGL’s stockholders. Under the 2021 Plan, the Company may grant ISOs, RSUs and other equity securities to acquire, to convert into or to receive up to 13,500,000 shares of Class A common stock. As of October 31, 2021, there were 13,500,000 share equivalents that remained available to issue under the 2021 Plan. All share equivalents issued or issuable under the 2014 Plan and the 2021 Plan (the “Stock Incentive Plans”) normally vest over a forty-eight month period with an initial catch up of 25 % vesting at the end of the first year during which no vesting occurs. In limited cases, vesting as short as twelve months with no cliff, vesting based on performance criteria and acceleration under certain events have also been permitted; however, such exceptions apply to less than 15 % of the share equivalents authorized under the Stock Incentive Plans. With regard to stock option grants, the exercise price of each ISO granted under the Stock Incentive Plans may not be less than the fair market value per share of the underlying Class A common stock on the date of grant. The Board of Directors establishes the term and the vesting of all options issued under the Stock Incentive Plans; however, in no event will the term exceed ten years . The fair value of each stock option and RSU award was originally estimated on the date of grant using the Black-Scholes Option Pricing Model using the independent valuations of the Company’s stock. The Company’s determination of the fair value of stock options and restricted stock units is affected by the Company’s stock price as well as a number of subjective and complex assumptions. These assumptions include the Company’s volatility, dividend yield, and risk-free interest rate. Presented below is a summary of the status of the stock options under the Stock Incentive Plan: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Intrinsic Value of outstanding options Outstanding at February 1, 2021 2,181,668 0.53 5.9 5,572,988 Granted - - - - Exercised ( 591,157 ) 0.52 5.2 7,287,806 Forfeited or expired ( 115,671 ) 0.57 5.5 - Outstanding at October 31, 2021 1,474,840 0.53 5.1 18,173,257 Exercisable at October 31, 2021 1,462,370 0.52 5.1 18,024,597 For the three months ended October 31, 2021 and 2020, the Company recorded $ 8 and $( 29 ) of compensation cost related to stock options, respectively. For the nine months ended October 31, 2021 and 2020, the Company recorded $ 40 and $ 27 of compensation cost related to stock options, respectively. The RSUs granted under the 2014 Plan contain an additional vesting requirement that, in addition to the applicable time or performance vesting criteria noted above, also requires the occurrence of a liquidity event. On the date of the Merger, the Board of Directors resolved that the Merger constituted a liquidity event, triggering the liquidity event criteria for vesting. As detailed in Note 3, in connection with the close of the Merger with Legacy LGL, the Company recognized a non-cash expense in the fiscal third quarter 2022 in an amount of $ 129,921 (Restated). Presented below is a summary of the status of outstanding RSUs, including showing the vesting status other than the liquidity event condition: Number of Shares Weighted Average Grant Date Fair Value Non-vested at February 1, 2021 9,712,169 $ 11.75 Granted 2,181,077 12.85 Vested ( 2,430,871 ) 12.85 Forfeited or expired ( 1,257,920 ) 12.85 Non-vested at October 31, 2021 8,204,455 $ 11.55 The fair value of each RSU was previously estimated on the date of grant using the Black-Scholes Option Pricing Model based on the same assumptions utilized for calculating fair market value of the stock options and utilizing the as converted equivalent price of securities issued during the period. As the closing of the Merger represented the satisfaction of the liquidity event vesting requirement for outstanding RSUs, and vesting was not probable until that time, all RSUs issued prior to the completion of the Merger were revalued using a fair value of $ 12.85 , which is the closing share price on that date. Stock compensation expense for ISOs is recognized on a straight line basis and with a provision for forfeitures matched to historical experience for matured grant cohorts. Stock compensation expense for RSUs is recognized on a graded basis matched to the length and vesting tranches for each grant. In the event that a RSU grant holder is terminated before the award is fully vested, the full amount of the unvested portion of the award will be recognized as a forfeiture in the period of termination. As of October 31, 2021, there was approximately $ 53,853 (Restated) of unrecognized compensation cost related to share-based compensation arrangements granted under the 2014 Plan, of which $ 3 remained for options and $ 53,850 (Restated) remained for RSUs, respectively. The fair value of the shares under stock options granted that vested, net of forfeitures, during the nine month periods ended October 31, 2021, and 2020 totaled $ 5,306 and $ 579 , respectively, primarily as a result of the forfeitures recognized during the periods exceeding previous estimates. Employee Stock Purchase Plan (‘ESPP’) In August 2021, Legacy LGL’s Board of Directors adopted, and its stockholders approved, the ESPP. The ESPP became effective immediately upon the Closing of the Merger. The purpose of the ESPP is to provide a means by which our eligible employees and certain designated companies may be given an opportunity to purchase shares of our common stock, to assist us in retaining the services of eligible employees, to secure and retain the services of new employees and to provide incentives for such persons to exert maximum efforts for our success. The Plan includes two components: a 423 Component and a Non-423 Component. We intend that the 423 Component will qualify as options issued under an “employee stock purchase plan” as that term is defined in Section 423(b) of the Code. Except as otherwise provided in the ESPP or determined by our board of directors, the Non-423 Component will operate and be administered in the same manner as the 423 Component. As of October 31, 2021, there were no purchases of shares for any eligible employee.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2021
Fair Value Measurements	7. Fair Value Measurements Fair value is defined as the price that would be received to sell an asset in an orderly transaction or paid to settle a liability in an orderly transaction between market participants at the measurement date. Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels, which are described below: a. Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets. b. Level 2 – Observable inputs other than quoted prices that are either directly or indirectly observable for the asset or liability. c. Level 3 – Unobservable inputs that are supported by little or no market activity. These levels are not necessarily an indication of the risk of liquidity associated with the financial assets or liabilities disclosed. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement, as required under ASC 820-10 “Fair Value Measurement.” Investments with an original maturity of three months or less at the date of purchase are considered cash equivalents, while all other investments are classified as short-term or long-term based on their maturities and their availability for use in current operations. The following table presents our assets measured at fair value on a recurring basis: October 31, 2021 January 31, 2021 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents $ 102 $ — $ — $ 102 $ 102 $ — $ — $ 102 Private Warrants — 43 — 43 — — — — Total assets $ 102 $ 43 $ — $ 145 $ 102 $ — $ — $ 102 The Company recognized a non-cash expense of $ 11,302 related to the change in fair value of warrants. At the effective date of the Merger, the Public Warrants were classified in equity at quoted prices (Level 1). Public Warrants are not revalued at the end of each reporting period.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2021
Loss Contingencies [Line Items]
Commitments and Contingencies	8. Commitments and Contingencies Contingencies In the ordinary course of business, the Company and its subsidiary may become defendants in certain shareholder claims and other litigation. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. To date, no such liability has been recorded. Leases The Company leases office space under the terms of noncancelable operating leases that expire at various dates through November 2026.Certain operating lease agreements provide for an annual 2.75 % escalation of the base rent. The Company is also responsible for operating expenses. The following is a schedule by year of the future minimum lease payments required under the Company’s operating leases: Remaining three months of fiscal 2022 286 2023 1,025 2024 755 2025 775 2026 775 Thereafter 1,455 $ 5,071 The Company is recognizing the total cost of its office leases ratably over the respective lease periods. The difference between rent paid and rent expense is reflected as deferred rent in the accompanying balance sheets. Rent expense totaled $ 257 and $ 296 for the three months ended October 31, 2021, and October 31, 2020, respectively. Rent expense totaled $ 849 and $ 1,697 for the nine months ended October 31, 2021, and October 31, 2020, respectively. In the second fiscal quarter of 2021, we completed lease buyouts of two office spaces in Maryland, for leases that were expiring in fiscal 2021 and fiscal 2022, and we have made payments of $ 394 to facilitate early terminations for those leases. Based on the Company moving to a more fully remote posture, we also decreased our lease portfolio in Japan and New York.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2021
Income Tax Disclosure [Line Items]
Income Taxes	9. Income Taxes The income tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate as adjusted for discrete items arising in that quarter. The effective income tax rate was ( 0.0 )% and ( 0.1 )% fo r the nine months ended October 31, 2021 and 2020, respectively. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company’s net domestic deferred tax assets and impact of foreign tax rate differential. On March 27, 2020, the CARES Act was enacted and signed into U.S. law to provide economic relief to individuals and businesses facing economic hardship as a result of the COVID-19 pandemic. Changes in tax laws or rates are accounted for in the period of enactment. The income tax provisions of the CARES Act did not have a significant impact on our current taxes, deferred taxes, or uncertain tax positions.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2021
Related Party Transaction [Line Items]
Related Party Transactions	10. Related Party Transactions (Restated) Product, subscription and support revenue from Related Parties Certain investors and companies who the Company is affiliated with purchased software, subscription and support revenue during the periods presented. The Company recognized $ 426 and $ 434 of revenue from contracts with related parties for the three months ending October 31, 2021, and October 31, 2020, respectively. The Company recognized $ 1,263 and $ 1,494 of revenue from contracts with related parties for the nine months ending October 31, 2021, and October 31, 2020, respectively. The corresponding receivable was $ 4,092 and $ 2,540 as of October 31, 2021, and January 31, 2021, respectively. Subscription Notes Receivables During the nine months ended October 31, 2021, the Company received pay offs of balances due of $ 843 . For the nine months ended October 31, 2020, the Company received paid offs of balances due of $ 48 . As of October 31, 2021, there are no remaining balances for subscription notes receivables. The subscription notes receivables’ accrued interest ranged from 1.40 % to 2.70 %, compounded annually.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Shareholders	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Shareholders	11. Net Loss Per Share Attributable to Common Stockholders Net Loss per common share The Company computes basic earnings per share (EPS) by dividing income (loss) available to common stockholders by the weighted average number of common shares outstanding for the reporting period. Diluted EPS reflects the effect of potential shares that would be issued if stock option awards, Restricted Stock Units, Public and Private Warrants and preferred shares, to the extent issued, were converted into common stock, to the extent dilutive. The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 (As Restated) (As Restated) Numerator: Net loss $ ( 162,949 ) $ ( 12,454 ) $ ( 195,616 ) $ ( 43,157 ) Denominator: Basic and Diluted Weighted-average shares in computing net loss per share attributable to common stockholders 87,178,432 65,067,942 74,001,217 64,064,424 Net loss attributable to common stockholders—basic and diluted $ ( 1.87 ) $ ( 0.19 ) $ ( 2.64 ) $ ( 0.67 ) Since the Company was in a net loss position for all periods presented, diluted net loss per share attributable to common stockholders will be the same as the basic net loss per share, as, in a net loss position, the inclusion of all potential common shares outstanding would be antidilutive. The potential shares of common stock excluded from the computation of diluted net loss per share for the periods presented due to their antidilutive impacts are as follows: As of October 31, 2021 As of October 31, 2020 Shares of common stock issuable from stock options 1,474,840 2,671,317 Total RSUs unvested pending settlement 8,204,455 16,102,029 Shares of common stock issuable upon conversion from preferred shares - 21,272,479 Private Warrants 10,200 — Public Warrants 8,596,273 — Potential common shares excluded from diluted net loss per share 18,285,768 40,045,825 As of October 31, 2020 there were no Private or Public Warrants outstanding due to the fact that the Legacy LGL interim condensed consolidated balance sheet was consolidated and combined with Legacy IronNet as of the effective date of the Merger. Legacy LGL Public and Private Warrants as of August 26, 2021 were 8,624,992 and 5,200,000 , respectively.

COVID-19 - CARES Act. provision

COVID-19 - CARES Act. provision	9 Months Ended
	Oct. 31, 2021
Risks and Uncertainties [Abstract]
COVID-19 - CARES Act. Provision	12. COVID-19 - CARES Act. provision During fiscal 2021, in response to the increased economic uncertainties that the impact of the COVID-19 pandemic was expected to have on our business, results of operations, liquidity and capital resources, Legacy IronNet took measures to ensure that we could continue the continuity of our business operations through the use of funding measures which included the Paycheck Protection Program (PPP) loan from the US Small Business Administration pursuant to the CARES Act. The purpose of the loan was for small businesses to keep their workforces employed through the pandemic. Legacy IronNet received loan funds of $ 5,580 on April 21, 2020. The loan bore interest at 1 % and was payable in monthly installments beginning on September 15, 2021 . As of October 31, 2021, and January 31, 2021, the Company had an interest accrual of $ 0 and $ 44 related to the PPP loan. The unsecured loan was evidenced by a promissory note of Legacy IronNet with PNC Bank (the “Lender”). As detailed in Note 3, on August 26, 2021, in conjunction with the Merger, the Company repaid in full all amounts due and terminated all commitments and obligations under the unsecured PPP loan. In addition to seeking and receiving the PPP loan under the CARES Act, Legacy IronNet also elected to defer the Company portion of payroll taxes under the CARES Act. Amounts deferred from March 1, 2020 through to the end of 2020 will become due, at 50 % on December 31, 2021, with the remaining 50 % due on December 31, 2022. The balance of the payroll tax deferral is $ 1,378 as of October 31, 2021 and is included in Other current and Long-Term Liabilities on the balance sheet.

Retirement Plans

Retirement Plans	9 Months Ended
	Oct. 31, 2021
Retirement Benefits [Abstract]
Retirement Plans	13. Retirement Plans We provide a retirement savings plan for the benefit of our employees, including our named executive officers. The plan is intended to qualify as a tax-qualified 401(k) plan so that contributions, and income earned on such contributions, are not taxable to participants until withdrawn or distributed from the plan (except in the case of contributions under the 401(k) plan designated as Roth contributions). The 401(k) plan provides that each participant may contribute up to an annual statutory limit. Participants who are at least 50 years old can also contribute additional amounts based on statutory limits for “catch-up” contributions. Under the plan, each employee is fully vested in his or her deferred salary contributions. Employee contributions are held and invested by the plan’s trustee as directed by participants. We also fully match employee contributions up to the first 4 % of salary, which amounts are fully vested.

Subsequent Events

Subsequent Events	9 Months Ended
	Oct. 31, 2021
SUBSEQUENT EVENTS	14. Subsequent Events The Company has evaluated subsequent events through the date the financial statements were originally issued, and has determined that the only material subsequent event that requires disclosure in the interim condensed consolidated financial statements is the approval on November 23, 2021 by the Compensation Committee of grants of 1,149,605 RSUs under the 2021 Plan for employees who had started with the company primarily after March 15, 2021, when the last grants under the 2014 Plan were made, and through November 15, 2021. Stock compensation amounts for the grants which had service periods beginning prior to October 31, 2021 will be included in stock compensation expense during the fourth quarter.

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Summary of revenue by geographical location	The following table presents revenue by geographic location: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 United States $ 6,226 $ 6,310 $ 17,210 $ 20,309 International 687 703 2,155 1,517 Total $ 6,913 $ 7,013 $ 19,365 $ 21,826

Restatement of Condensed Cons_2

Restatement of Condensed Consolidated Financial Statements (Tables)	9 Months Ended
	Oct. 31, 2021
Accounting Changes and Error Corrections [Abstract]
Schedule of the effect of restatement to the Company's financial statements	As of October 31, 2021 Balance Sheet As Previously Reported Adjustments As Restated Assets Current assets: Accounts receivable $ 2,246 $ 2,429 $ 4,675 Unbilled receivables 3,885 1,179 5,064 Related party receivables and loan receivables 3,521 571 4,092 Account and loan receivable 9,652 4,179 13,831 Total current assets 93,699 4,179 97,878 Total assets $ 102,002 $ 4,179 $ 106,181 Liabilities and stockholders' equity Current liabilities: Deferred Revenue $ 12,929 $ 3,450 $ 16,379 Total current liabilities 24,483 3,450 27,933 Deferred Revenue 17,181 729 17,910 Total liabilities $ 43,204 $ 4,179 $ 47,383 Stockholders' equity Additional paid-in capital $ 459,349 $ ( 30,173 ) $ 429,176 Accumulated deficit ( 400,828 ) 30,173 ( 370,655 ) Total liabilities and stockholders' equity $ 102,002 $ 4,179 $ 106,181 3 Months Ended October 31, 2021 9 Months Ended October 31, 2021 Statement of Operations As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Research and development $ 28,144 $ ( 3,689 ) $ 24,455 $ 42,606 $ ( 3,689 ) $ 38,917 Sales and marketing 57,196 ( 5,952 ) 51,244 72,046 ( 5,951 ) 66,095 General and administrative 100,267 ( 20,532 ) 79,735 111,952 ( 20,533 ) 91,419 Operating Expenses 185,607 ( 30,173 ) 155,434 226,604 ( 30,173 ) 196,432 Operating Loss ( 181,062 ) 30,173 ( 150,889 ) ( 213,361 ) 30,173 ( 183,188 ) Loss before income taxes ( 193,088 ) 30,173 ( 162,915 ) ( 225,733 ) 30,173 ( 195,560 ) Benefit (provision) for income taxes ( 34 ) - ( 34 ) ( 56 ) - ( 56 ) Net loss ( 193,122 ) 30,173 ( 162,949 ) ( 225,789 ) 30,173 ( 195,616 ) Basic and diluted net loss per common share $ ( 2.22 ) $ 0.35 $ ( 1.87 ) $ ( 3.05 ) $ 0.41 $ ( 2.64 ) 9 Months Ended October 31, 2021 Statement of Cash Flows As Previously Reported Adjustments As Restated Cash flows from operating activities Net Loss $ ( 225,789 ) $ 30,173 $ ( 195,616 ) Employee stock based compensation 160,156 ( 30,173 ) 129,983 Change in Operating Assets and Liabilities Accounts receivable ( 2,984 ) ( 4,179 ) ( 7,163 ) Deferred revenue ( 3,934 ) 4,179 245 Net cash used in operating activities $ ( 59,095 ) $ - $ ( 59,095 ) 3 Months Ended October 31, 2021 9 Months Ended October 31, 2021 Statements of Comprehensive Loss As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Net loss $ ( 193,122 ) $ 30,173 $ ( 162,949 ) $ ( 225,789 ) $ 30,173 $ ( 195,616 ) Comprehensive loss $ ( 192,819 ) $ 30,173 $ ( 162,646 ) $ ( 225,561 ) $ 30,173 $ ( 195,388 ) Statement of Changes in Stockholders' Equity for the 3 months Ended October 31, 2021 Additional Paid-In Capital Accumulated Deficit Total Stockholders' Equity As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Stock-based compensation $ 160,129 $ ( 30,173 ) $ 129,956 $ 160,129 $ ( 30,173 ) $ 129,956 Net loss ( 193,122 ) 30,173 ( 162,949 ) ( 193,122 ) 30,173 ( 162,949 ) Balance at October 31, 2021 $ 459,349 $ ( 30,173 ) $ 429,176 $ ( 400,828 ) $ 30,173 $ ( 370,655 ) $ 58,798 $ - $ 58,798 Statement of Changes in Stockholders' Equity for the 9 months Ended October 31, 2021 Additional Paid-In Capital Accumulated Deficit Total Stockholders' Equity As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Stock-based compensation $ 160,156 $ ( 30,173 ) $ 129,983 $ 160,156 $ ( 30,173 ) $ 129,983 Net loss ( 225,789 ) 30,173 ( 195,616 ) ( 225,789 ) 30,173 ( 195,616 ) Balance at October 31, 2021 $ 459,349 $ ( 30,173 ) $ 429,176 $ ( 400,828 ) $ 30,173 $ ( 370,655 ) $ 58,798 $ - $ 58,798

Reverse Recapitalization (Table

Reverse Recapitalization (Tables)	9 Months Ended
	Oct. 31, 2021
Business Combinations [Abstract]
Summary Of Reconcile Elements Of The Business Combination	The following table reconciles the elements of the Merger to the condensed consolidated statement of cash flows for the nine months ended October 31, 2021: Recapitalization and associated transactions Cash (Trust) $ 173,015 Redemptions ( 159,763 ) Less: fees to underwriters and advisors ( 9,038 ) Net cash received from Merger recapitalization 4,214 Issuance of PIPE Shares 125,000 Less: PIPE fees to underwriters and advisors ( 21,179 ) Net cash received from PIPE Shares and Merger recapitalization 108,035 Less: debt settlement ( 21,266 ) Net proceeds from Merger recapitalization, PIPE Shares and debt settlement $ 86,769
Summary Of Common Stock Issued Following The Consummation Of The Business Combination	The number of outstanding shares of common stock of the Company as of October 31, 2021 is summarized as follows: Shares by Type Number of shares IronNet Class A Common Stock outstanding previous to the Merger 67,501,813 Issuance of common stock (exercises of ISOs and warrant) 28,734 Number of Shares issued at the date of the business combination ( Recapitalization) LGL Class A Common Stock outstanding previous to the Merger 17,250,000 Less: Redemption of LGL Class A previous to the Merger ( 15,928,889 ) Total Class A Shares issued to former LGL shareholders 1,321,111 LGL Founders Shares 3,234,375 PIPE Shares 12,500,000 Number of Share issued at the Merger 17,055,486 Number of Shares issued (redeemed) following the consummation of the Merger Earnout Shares 1,078,125 Private Warrants (Exercised) 3,188,229 Public Warrants (Exercised) 28,719 Payments on subscription notes receivable ( 54,955 ) Shares repurchase related to loan pay-off ( 107,521 ) Total Shares of Common Stock as of October 31, 2021 88,718,630

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Schedule of Customers That Represent 10% or More of the Company's Total Revenue	The following table presents customers that represent 10% or more of the Company’s total revenue: For the Three Months Ended October 31, For the Nine Months Ended October 31, 2021 2020 2021 2020 Customer A 12 % * 11 % * Customer B 11 % 15 % 11 % * Customer C * * * 10 % 23 % 15 % 22 % 10 % * - less than 10 %
Schedule of Deferred Costs	The Company defers contract fulfillment costs that include appliance hardware. The balances in deferred costs are as follows: Balance at February 1, 2021 $ 2,805 Cost of revenue recognized ( 1,033 ) Costs deferred 473 Foreign exchange ( 3 ) Balance at October 31, 2021 $ 2,242 Balance at February 1, 2020 3,080 Cost of revenue recognized ( 832 ) Costs deferred 711 Foreign exchange ( 3 ) Balance at October 31, 2020 $ 2,956
Schedule of Deferred Revenue	The balance in deferred revenue is as follows: (As Restated) Balance at February 1, 2021 $ 34,044 Revenue recognized ( 23,687 ) Revenue deferred 23,944 Foreign exchange ( 12 ) Balance at October 31, 2021 $ 34,289 Balance at February 1, 2020 20,312 Revenue recognized ( 19,507 ) Revenue deferred 22,196 Foreign exchange - Balance at October 31, 2020 $ 23,001
Schedule of Company's Recognition of Revenue	The Company’s recognition of revenue in the future thereon will be as follows: Years Ending January 31, 2022 (3 months) $ 7,413 2023 12,477 2024 8,382 2025 4,466 2026 1,551 $ 34,289

Stock Incentive Plan (Tables)

Stock Incentive Plan (Tables)	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Summary of Status of Stock Options Under Stock Incentive Plan	Presented below is a summary of the status of the stock options under the Stock Incentive Plan: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Intrinsic Value of outstanding options Outstanding at February 1, 2021 2,181,668 0.53 5.9 5,572,988 Granted - - - - Exercised ( 591,157 ) 0.52 5.2 7,287,806 Forfeited or expired ( 115,671 ) 0.57 5.5 - Outstanding at October 31, 2021 1,474,840 0.53 5.1 18,173,257 Exercisable at October 31, 2021 1,462,370 0.52 5.1 18,024,597
Summary of Status of Outstanding RSU's	The RSUs granted under the 2014 Plan contain an additional vesting requirement that, in addition to the applicable time or performance vesting criteria noted above, also requires the occurrence of a liquidity event. On the date of the Merger, the Board of Directors resolved that the Merger constituted a liquidity event, triggering the liquidity event criteria for vesting. As detailed in Note 3, in connection with the close of the Merger with Legacy LGL, the Company recognized a non-cash expense in the fiscal third quarter 2022 in an amount of $ 129,921 (Restated). Presented below is a summary of the status of outstanding RSUs, including showing the vesting status other than the liquidity event condition: Number of Shares Weighted Average Grant Date Fair Value Non-vested at February 1, 2021 9,712,169 $ 11.75 Granted 2,181,077 12.85 Vested ( 2,430,871 ) 12.85 Forfeited or expired ( 1,257,920 ) 12.85 Non-vested at October 31, 2021 8,204,455 $ 11.55

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2021
Schedule of assets measured at fair value on a recurring basis	The following table presents our assets measured at fair value on a recurring basis: October 31, 2021 January 31, 2021 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents $ 102 $ — $ — $ 102 $ 102 $ — $ — $ 102 Private Warrants — 43 — 43 — — — — Total assets $ 102 $ 43 $ — $ 145 $ 102 $ — $ — $ 102

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of future minimum lease payments required under operating leases	The following is a schedule by year of the future minimum lease payments required under the Company’s operating leases: Remaining three months of fiscal 2022 286 2023 1,025 2024 755 2025 775 2026 775 Thereafter 1,455 $ 5,071

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Shareholders (Tables)	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders	The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 (As Restated) (As Restated) Numerator: Net loss $ ( 162,949 ) $ ( 12,454 ) $ ( 195,616 ) $ ( 43,157 ) Denominator: Basic and Diluted Weighted-average shares in computing net loss per share attributable to common stockholders 87,178,432 65,067,942 74,001,217 64,064,424 Net loss attributable to common stockholders—basic and diluted $ ( 1.87 ) $ ( 0.19 ) $ ( 2.64 ) $ ( 0.67 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The potential shares of common stock excluded from the computation of diluted net loss per share for the periods presented due to their antidilutive impacts are as follows: As of October 31, 2021 As of October 31, 2020 Shares of common stock issuable from stock options 1,474,840 2,671,317 Total RSUs unvested pending settlement 8,204,455 16,102,029 Shares of common stock issuable upon conversion from preferred shares - 21,272,479 Private Warrants 10,200 — Public Warrants 8,596,273 — Potential common shares excluded from diluted net loss per share 18,285,768 40,045,825

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies - Additional Information (Details) $ / shares in Units, $ in Thousands	Aug. 26, 2021USD ($)$ / sharesshares	Aug. 15, 2021USD ($)$ / sharesshares	Oct. 31, 2021USD ($)$ / sharesshares	Oct. 31, 2020USD ($)	Oct. 31, 2021USD ($)Segment$ / sharesshares	Oct. 31, 2020USD ($)	Jan. 31, 2021USD ($)
Organization And Summary Of Significant Accounting Policies [Line Items]
Proceeds from PIPE shares					$ 125,000
Transaction costs	$ 9,038	$ 21,180
Recapitalization	$ 13,251
Change in net unrealized gains (losses) on available for sale investments, net of tax				$ (397)		$ (398)
Research and development			$ 24,455	$ 5,687	38,917	19,965
Cash and cash equivalents			$ 73,891		$ 73,891		$ 31,543
Number Of Operating Segments | Segment					1
Warrants issued | shares			8,606,473		8,606,473
Shares Issued, Price Per Share | $ / shares			$ 12.85		$ 12.85
Number of shares Right to receive on occurrence of Earnout event | shares	1,078
Change in fair value of warrants liabilities					$ 11,302
Public Warrants [Member]
Organization And Summary Of Significant Accounting Policies [Line Items]
Change in fair value in additional paid in capital					$ 15,740
Warrants issued | shares			8,596,273		8,596,273
Change in fair value of warrants liabilities					$ 15,740
Private Warrants [Member]
Organization And Summary Of Significant Accounting Policies [Line Items]
Warrants issued | shares			10,200		10,200
PIPE Shares [Member]
Organization And Summary Of Significant Accounting Policies [Line Items]
Issuance of common stock (in Shares) | shares	12,500,000	12,500,000
Proceeds from PIPE shares	$ 125,000	$ 125,000
Shares Issued, Price Per Share | $ / shares	$ 10	$ 10
IronNet Cybersecurity Inc [Member] | Business Combination Agreement [Member]
Organization And Summary Of Significant Accounting Policies [Line Items]
Number of consecutive trading days for determining the share price	10 days
Common stock diluted exchange ratio	0.8141070
IronNet Cybersecurity Inc [Member] | Business Combination Agreement [Member] | Share Price Equals Or Exceeds Dollars Thirteen [Member]
Organization And Summary Of Significant Accounting Policies [Line Items]
Shares Issued, Price Per Share | $ / shares	$ 13

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies - Summary of Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Organization And Summary Of Significant Accounting Policies [Line Items]
Total revenue	$ 6,913	$ 7,013	$ 19,365	$ 21,826
United States [Member]
Organization And Summary Of Significant Accounting Policies [Line Items]
Total revenue	6,226	6,310	17,210	20,309
International [Member]
Organization And Summary Of Significant Accounting Policies [Line Items]
Total revenue	$ 687	$ 703	$ 2,155	$ 1,517

Restatement of Condensed Cons_3

Restatement of Condensed Consolidated Financial Statements - Additional Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Jan. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Out of period adjustments	$ 30,200
Unbilled receivable	5,064	$ 1,425
Related party receivables	4,092	$ 3,599
Restatement and Revision Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accounts receivable	2,400
Unbilled receivable	1,200
Related party receivables	600
Deferred revenue related to contracts with customers	$ 4,200

Restatement of Condensed Cons_4

Restatement of Condensed Consolidated Financial Statements - Schedule of the effect of restatement to the Company's financial statements (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Jul. 31, 2021	Jan. 31, 2021	Jul. 31, 2020	Jan. 31, 2020
Current assets
Accounts receivable	$ 4,675		$ 4,675			$ 1,643
Unbilled receivable	5,064		5,064			1,425
Related party receivables and loan receivables	4,092		4,092			3,599
Account and loan receivables	13,831		13,831			6,667
Total current assets	97,878		97,878			45,667
Total assets	106,181		106,181			51,691
Current liabilities:
Deferred revenue	16,379		16,379			12,481
Total current liabilities	27,933		27,933			21,392
Deferred revenue	17,910		17,910			21,563
Total liabilities	47,383		47,383			46,665
Stockholders' equity
Additional paid-in capital	429,176		429,176			180,853
Accumulated deficit	(370,655)		(370,655)			(175,039)
Total liabilities and stockholders' equity	106,181		106,181			51,691
Operating expenses
Research and development	24,455	$ 5,687	38,917	$ 19,965
Sales and marketing	51,244	7,155	66,095	23,265
General and administrative	79,735	4,715	91,419	16,690
Operating Expenses	155,434	17,557	196,431	59,920
Operating Loss	(150,889)	(12,613)	(183,188)	(43,224)
Loss before income taxes	(162,915)	(12,435)	(195,560)	(43,099)
Benefit (provision) for income taxes	34	19	56	58
Net loss	$ (162,949)	$ (12,454)	$ (195,616)	$ (43,157)
Basic and diluted net loss per common share	$ (1.87)	$ (0.19)	$ (2.64)	$ (0.67)
Cash flows from operating activities
Employee stock based compensation			$ 129,983	$ 27
Changes in operating assets and liabilities:
Accounts receivable			7,163	962
Deferred revenue			(245)	2,689
Net cash used in operating activities			(59,095)	(39,897)
Comprehensive loss	$ (162,646)	$ (12,905)	(195,388)	(43,559)
Stock-based compensation	129,956	(29)	129,983	27
Balance	58,798	3,664	58,798	3,664	$ (27,101)	5,026	$ 14,104	$ 3,069
As Previously Reported
Current assets
Accounts receivable	2,246		2,246
Unbilled receivable	3,885		3,885
Related party receivables and loan receivables	3,521		3,521
Account and loan receivables	9,652		9,652
Total current assets	93,699		93,699
Total assets	102,002		102,002
Current liabilities:
Deferred revenue	12,929		12,929
Total current liabilities	24,483		24,483
Deferred revenue	17,181		17,181
Total liabilities	43,204		43,204
Stockholders' equity
Additional paid-in capital	459,349		459,349
Accumulated deficit	(400,828)		(400,828)
Total liabilities and stockholders' equity	102,002		102,002
Operating expenses
Research and development	28,144		42,606
Sales and marketing	57,196		72,046
General and administrative	100,267		111,952
Operating Expenses	185,607		226,604
Operating Loss	(181,062)		(213,361)
Loss before income taxes	(193,088)		(225,733)
Benefit (provision) for income taxes	34		56
Net loss	$ (193,122)		$ (225,789)
Basic and diluted net loss per common share	$ (2.22)		$ (3.05)
Cash flows from operating activities
Employee stock based compensation			$ 160,156
Changes in operating assets and liabilities:
Accounts receivable			2,984
Deferred revenue			(3,934)
Net cash used in operating activities			(59,095)
Comprehensive loss	$ (192,819)		(225,561)
Stock-based compensation	160,129		160,156
Balance	58,798		58,798
Adjustments
Current assets
Accounts receivable	2,429		2,429
Unbilled receivable	1,179		1,179
Related party receivables and loan receivables	571		571
Account and loan receivables	4,179		4,179
Total current assets	4,179		4,179
Total assets	4,179		4,179
Current liabilities:
Deferred revenue	3,450		3,450
Total current liabilities	3,450		3,450
Deferred revenue	729		729
Total liabilities	4,179		4,179
Stockholders' equity
Additional paid-in capital	(30,173)		(30,173)
Accumulated deficit	30,173		30,173
Total liabilities and stockholders' equity	4,179		4,179
Operating expenses
Research and development	(3,689)		(3,689)
Sales and marketing	(5,952)		(5,951)
General and administrative	(20,532)		(20,533)
Operating Expenses	(30,173)		(30,173)
Operating Loss	30,173		30,173
Loss before income taxes	30,173		30,173
Benefit (provision) for income taxes	0		0
Net loss	$ 30,173		$ 30,173
Basic and diluted net loss per common share	$ 0.35		$ 0.41
Cash flows from operating activities
Employee stock based compensation			$ (30,173)
Changes in operating assets and liabilities:
Accounts receivable			4,179
Deferred revenue			4,179
Comprehensive loss	$ 30,173		30,173
Stock-based compensation	(30,173)		(30,173)
As Restated
Current assets
Accounts receivable	4,675		4,675
Unbilled receivable	5,064		5,064
Related party receivables and loan receivables	4,092		4,092
Account and loan receivables	13,831		13,831
Total current assets	97,878		97,878
Total assets	106,181		106,181
Current liabilities:
Deferred revenue	16,379		16,379
Total current liabilities	27,933		27,933
Deferred revenue	17,910		17,910
Total liabilities	47,383		47,383
Stockholders' equity
Additional paid-in capital	429,176		429,176
Accumulated deficit	(370,655)		(370,655)
Total liabilities and stockholders' equity	106,181		106,181
Operating expenses
Research and development	24,455		38,917
Sales and marketing	51,244		66,095
General and administrative	79,735		91,419
Operating Expenses	155,434		196,432
Operating Loss	(150,889)		(183,188)
Loss before income taxes	(162,915)		(195,560)
Benefit (provision) for income taxes	34		56
Net loss	$ (162,949)		$ (195,616)
Basic and diluted net loss per common share	$ (1.87)		$ (2.64)
Cash flows from operating activities
Employee stock based compensation			$ 129,983
Changes in operating assets and liabilities:
Accounts receivable			7,163
Deferred revenue			(245)
Net cash used in operating activities			(59,095)
Comprehensive loss	$ (162,646)		(195,388)
Stock-based compensation	129,956
Balance	58,798		58,798
Additional Paid-in Capital [Member]
Changes in operating assets and liabilities:
Stock-based compensation	129,956	(29)	129,983	27
Balance	429,176	167,353	429,176	167,353	181,181	180,853	164,929	$ 123,235
Additional Paid-in Capital [Member] | As Previously Reported
Changes in operating assets and liabilities:
Stock-based compensation	160,129		160,156
Balance	459,349		459,349
Additional Paid-in Capital [Member] | Adjustments
Changes in operating assets and liabilities:
Stock-based compensation	(30,173)		(30,173)
Balance	(30,173)		(30,173)
Additional Paid-in Capital [Member] | As Restated
Changes in operating assets and liabilities:
Stock-based compensation	129,956		129,983
Balance	429,176		429,176
Retained Earnings [Member]
Changes in operating assets and liabilities:
Balance	(370,655)	$ (162,823)	(370,655)	$ (162,823)	$ (207,706)	$ (175,039)	$ (150,369)
Retained Earnings [Member] | As Previously Reported
Operating expenses
Net loss	(193,122)		(225,789)
Changes in operating assets and liabilities:
Balance	(400,828)		(400,828)
Retained Earnings [Member] | Adjustments
Operating expenses
Net loss	30,173		30,173
Changes in operating assets and liabilities:
Balance	30,173		30,173
Retained Earnings [Member] | As Restated
Operating expenses
Net loss	(162,949)		(195,616)
Changes in operating assets and liabilities:
Balance	$ (370,655)		$ (370,655)

Reverse Recapitalization - Summ

Reverse Recapitalization - Summary of Reconcile Elements of the Merger (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2021USD ($)
Business Combinations [Abstract]
Cash (Trust)	$ 173,015
Redemptions	(159,763)
Less: fees to underwriters and advisors	(9,038)
Net cash received from Merger recapitalization	4,214
Issuance of PIPE Shares	125,000
Less: PIPE fees to underwriters and advisors	(21,179)
Net cash received from PIPE Shares and Merger recapitalization	108,035
Less: debt Settlement	(21,266)
Net proceeds from Merger recapitalization, PIPE Shares and debt settlement	$ 86,769

Reverse Recapitalization - Su_2

Reverse Recapitalization - Summary of Common Stock Outstanding Following The Consummation Of The Business Combination (Details) - shares	Oct. 31, 2021	Jan. 31, 2021
Business Acquisition [Line Items]
Shares outstanding (in Shares)	88,718,630
LGL SYSTEMS ACQUISITION CORP [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	17,055,486
IronNet Class A Common Stocks [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	67,501,813
Issuance of Common Stock [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	28,734
LGL Class A Common Stocks [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	17,250,000
Redemption of LGL Class A [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	15,928,889
Class A Common Stock
Business Acquisition [Line Items]
Shares outstanding (in Shares)	88,718,630	65,353,098
Class A Common Stock | LGL SYSTEMS ACQUISITION CORP [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	1,321,111
LGL Founders Shares [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	3,234,375
PIPE Shares [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	12,500,000
Earnout Shares [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	1,078,125
Private Warrants (Exercised) [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	3,188,229
Public Warrants (Exercised) [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	28,719
Payments on Subscription Notes Receivable [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	54,955
Shares Repurchase Related to Loan Pay Off [Member]
Business Acquisition [Line Items]
Shares outstanding (in Shares)	107,521

Reverse Recapitalization (Addit

Reverse Recapitalization (Additional Information) (Details) - USD ($)	Sep. 10, 2021	Aug. 26, 2021	Aug. 15, 2021	Apr. 21, 2020	Dec. 29, 2018	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2021	Oct. 31, 2020	Jun. 21, 2021	Jan. 31, 2021
Business Acquisition [Line Items]
Proceeds from PIPE shares										$ 125,000,000
Business Combination Bonus Payment Made To Management And Employees							$ 500,000		$ 500,000	500,000
Transaction cost related to merger									$ 1,556,000	$ 2,328,000
Share issued, price per share							$ 12.85		$ 12.85	$ 12.85
Aggregate purchase price							$ 10,000	$ 2,450,000		$ 305,000	$ 44,080,000
Debt instrument face amount												$ 15,000,000
Repayment of term loan and interest		$ 15,609,000
Principal amount					$ 1,000,000
Rate of interest					2.76%
Shares surrender in conjunction to merger					107,521
Non cash expense							$ 8,000	$ (29,000)		$ 40,000	$ 27,000
Non vested number of shares		16,634,972					8,204,455		8,204,455	8,204,455			9,712,169
PIPE Shares [Member]
Business Acquisition [Line Items]
Proceeds from PIPE shares		$ 125,000,000	$ 125,000,000
Number of shares issued		12,500,000	12,500,000
Share issued, price per share		$ 10	$ 10
Sale of gross proceeds		$ 125,000
Earnout Shares [Member]
Business Acquisition [Line Items]
Number of shares issued	1,078,125
LGL Founders Shares [Member]
Business Acquisition [Line Items]
Number of shares issued										3,234,375
Share issued, price per share							$ 0.007		$ 0.007	$ 0.007
Aggregate purchase price										$ 24,000
Forecast [Member]
Business Acquisition [Line Items]
Non cash expense						$ 129,921,000
Payback Protection Program Loan [Member] | CARES Act [Member]
Business Acquisition [Line Items]
Interest rate				1.00%
Debt instrument face amount				$ 5,580,000
Interest accrual on loan							$ 0		$ 0	$ 0			$ 44,000
Debt instrument frequency of periodic payment				monthly
Debt instrument date of first required payment				Sep. 15, 2021

Revenues - Additional Informati

Revenues - Additional Information (Details) - USD ($) $ in Thousands	Jan. 31, 2021	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue remaining performance obligation amount		$ 34,289		$ 34,289
Deferred commission expenses	$ 1,319	1,494		1,494
Other Current Assets [Member]
Disaggregation of Revenue [Line Items]
Deferred commission expenses		1,061		1,061
Other Noncurrent Assets [Member]
Disaggregation of Revenue [Line Items]
Deferred commission expenses		433		433
One Customer [Member]
Disaggregation of Revenue [Line Items]
Revenue from contract with customers excluding assessed tax					$ 2,174
Two Customers [Member]
Disaggregation of Revenue [Line Items]
Revenue from contract with customers excluding assessed tax				$ 4,283
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage					10.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage				22.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Maximum [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage				10.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Minimum [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage				10.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	85.00%			60.00%
Subscription Revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from contract with customers excluding assessed tax		3,792	$ 2,180	$ 10,993	$ 6,475
Product Subscription And Support Revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from contract with customers excluding assessed tax		$ 6,092	$ 4,432	$ 17,992	$ 13,231

Revenue - Schedule of Customers

Revenue - Schedule of Customers That Represent 10% or More of the Company's Total Revenue (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Customer A [Member]
Concentration Risk [Line Items]
Concentration risk percentage	12.00%		11.00%
Customer B [Member]
Concentration Risk [Line Items]
Concentration risk percentage	11.00%	15.00%	11.00%
Customer C [Member]
Concentration Risk [Line Items]
Concentration risk percentage				10.00%
Total Customer [Member]
Concentration Risk [Line Items]
Concentration risk percentage	23.00%	15.00%	22.00%	10.00%

Revenue - Schedule of Custome_2

Revenue - Schedule of Customers That Represent 10% or More of the Company's Total Revenue (Parenthetical) (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Maximum [Member]
Concentration Risk [Line Items]
Concentration risk percentage			10.00%
Customer A [Member]
Concentration Risk [Line Items]
Concentration risk percentage	12.00%		11.00%
Customer B [Member]
Concentration Risk [Line Items]
Concentration risk percentage	11.00%	15.00%	11.00%
Customer C [Member]
Concentration Risk [Line Items]
Concentration risk percentage				10.00%

Revenue - Schedule of Deferred

Revenue - Schedule of Deferred Costs (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Beginning Balance	$ 2,805	$ 3,080
Cost of revenue recognized	(1,033)	(832)
Costs deferred	473	711
Foreign exchange	(3)	(3)
Ending Balance	$ 2,242	$ 2,956

Revenue - Schedule of Deferre_2

Revenue - Schedule of Deferred Revenue (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Beginning Balance	$ 34,044	$ 20,312
Revenue recognized	(23,687)	(19,507)
Revenue deferred	23,944	22,196
Foreign exchange	(12)	0
Ending Balance	$ 34,289	$ 23,001

Revenues - Schedule of Company'

Revenues - Schedule of Company's Recognition of Revenue (Details) $ in Thousands	Oct. 31, 2021USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue remaining performance obligation amount	$ 34,289
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	3 months
Revenue remaining performance obligation amount	$ 7,413
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation amount	$ 12,477
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation amount	$ 8,382
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation amount	$ 4,466
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation amount	$ 1,551

Equity - Additional Information

Equity - Additional Information (Details) $ / shares in Units, $ in Thousands	1 Months Ended	9 Months Ended
	Oct. 31, 2021USD ($)Vote$ / sharesshares	Oct. 31, 2021USD ($)Vote$ / sharesshares	Oct. 31, 2020USD ($)	Jan. 31, 2021$ / sharesshares
Stockholders' Equity (Details) [Line Items]
Preferred stock authorized to issue	100,000,000	100,000,000		100,000,000
Preferred stock par value (in Dollars per share) | $ / shares	$ 0.0001	$ 0.0001		$ 0.0001
Preferred Stock, Shares Issued	0	0		0
Preferred Stock, Shares Outstanding	0	0		0
Purchased share price (in Dollars per share) | $ / shares	$ 12.85	$ 12.85
Common stock, shares outstanding	88,718,630	88,718,630
Change in fair value of warrants liabilities | $		$ 11,302
Private Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate amount of purchased shares (in Shares)		5,200,000
Purchased share price (in Dollars per share) | $ / shares	$ 1	$ 1
Sale of Stock, Consideration Received on Transaction | $		$ 5,200
Not exercised warrants	10,200	10,200
Number of private warrants exercised	5,189,800	5,189,800
Change in fair value of warrants liabilities | $		$ 11,302
Public Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Not exercised warrants	8,596,273	8,596,273
Sale price of common stock | $ / shares	$ 18	$ 18
Exercise of warrants	28,719
Proceeds from exercise of warrants | $	$ 330
Public warrants exercised price | $ / shares	$ 11.50	$ 11.50
Public warrants expiration period		5 years
Price per warrant | $ / shares	$ 0.01	$ 0.01
Common Class A [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, share authorized	500,000,000	500,000,000		500,000,000
Common shares, votes per share | Vote	1	1
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001	$ 0.0001		$ 0.0001
Common stock, shares issued	88,718,630	88,718,630		65,353,098
Common stock, shares outstanding	88,718,630	88,718,630		65,353,098
Common Class A [Member] | Private Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Purchased share price (in Dollars per share) | $ / shares	$ 11.50	$ 11.50
Private warrants redeemed	3,188,229	3,188,229
Aggregate of shares (in Shares)	0.6	0.6

Stock Incentive Plan - Addition

Stock Incentive Plan - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Aug. 26, 2021	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Nov. 23, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation by share based arrangement percentage of shares authorized for grant for which no condition is there			15.00%		15.00%
Share based compensation by share based arrangement term					10 years
Allocated share based compensation			$ 8	$ (29)	$ 40	$ 27
Share based payment arrangementnon vested award options cost not yet recognized amount			53,853		53,853
Share based payment arrangementnon vested award excluding options cost not yet recognized amount			3		3
Share based payment arrangementnon vested award cost not yet recognized amount			$ 53,850		$ 53,850
Share issued, price per share			$ 12.85		$ 12.85
Share based compensation by share based award options forfeited in period aggregate fair value					$ 5,306	$ 579
Forecast [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share based compensation		$ 129,921
Stock Incentive Plan [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation by share based arrangement vesting period					48 months
Share based compensation by share based arrangement vesting arrangement term					25.00%
Stock Incentive Plan [Member] | Common Class A [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation by share based arrangement number of shares available for grant			13,500,000		13,500,000
Stock Incentive Plan [Member] | Common Class A [Member] | Maximum [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation by share based arrangement number of shares authorized			13,500,000		13,500,000
2014 Equity Incentive Plan [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Conversion of stock, shares converted	18,971,549
2021 Equity Incentive Plan [Member] | Subsequent Event [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share based compensation by share based arrangement number of shares available for grant							1,149,605

Stock Incentive Plan - Summary

Stock Incentive Plan - Summary of Status of Stock Options Under Stock Incentive Plan (Details) - USD ($)	Jan. 31, 2021	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Number of Shares, Beginning Balance		2,181,668
Number of Shares, Exercised		(591,157)
Number of Shares, Forfeited or expired		(115,671)
Number of Shares, Ending Balance	2,181,668	1,474,840
Number of Shares, Exercisable		1,462,370
Weighted Average Exercise Price, Beginning Balance		$ 0.53
Weighted Average Exercise Price, Exercised		0.52
Weighted Average Exercise Price, Forfeited or expired		0.57
Weighted Average Exercise Price, Ending Balance	$ 0.53	0.53
Weighted Average Exercise Price, Exercisable		$ 0.52
Weighted Average Remaining Contractual Term, Outstanding	5 years 10 months 24 days	5 years 1 month 6 days
Weighted Average Remaining Contractual Term, Exercised		5 years 2 months 12 days
Weighted Average Remaining Contractual Term, Forfeitures or expired		5 years 6 months
Weighted Average Remaining Contractual Term, Exercisable		5 years 1 month 6 days
Intrinsic Value of Outstanding Options, Beginning Balance		$ 5,572,988
Intrinsic Value of Outstanding Options, Exercised		7,287,806
Intrinsic Value of Outstanding Options, Ending Balance	$ 5,572,988	18,173,257
Intrinsic Value of Outstanding Options, Exercisable		$ 18,024,597

Stock Incentive Plan - Summar_2

Stock Incentive Plan - Summary of Status of Outstanding RSU's (Details)	9 Months Ended
	Oct. 31, 2021$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of Shares, Beginning Balance | shares	9,712,169
Number of Shares, Granted | shares	2,181,077
Number of Shares, Vested | shares	(2,430,871)
Number of Shares, Forfeited or expired | shares	(1,257,920)
Number of Shares, Ending Balance | shares	8,204,455
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares	$ 11.75
Weighted Average Grant Date Fair Value, Granted | $ / shares	12.85
Weighted Average Grant Date Fair Value, Vested | $ / shares	12.85
Weighted Average Grant Date Fair Value, Forfeited or expired | $ / shares	12.85
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares	$ 11.55

Fair Value Measurements- Additi

Fair Value Measurements- Additional Information (Details) $ in Thousands	3 Months Ended
	Oct. 31, 2021USD ($)
Private Warrants [Member]
Change in fair value of warrant liabilities	$ 11,302

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 102	$ 102
Private Warrants	43
Total assets	145	102
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	102	102
Total assets	102	$ 102
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Private Warrants	43
Total assets	$ 43

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	4 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Commitments And Contingencies Disclosure [Line Items]
Percentage of annual escalation of base rent			2.75%
Rent expense	$ 257	$ 296	$ 849	$ 1,697
Payments to facilitate early terminations of leases			$ 394

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Future Minimum Lease Payments Required Under Operating Leases (Details) $ in Thousands	Oct. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remaining three months of fiscal 2022	$ 286
2023	1,025
2024	755
2025	775
2026	775
Thereafter	1,455
Total	$ 5,071

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Income Tax [Line Items]
Effective income tax rate	(0.00%)	(0.10%)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Jan. 31, 2021
Related Party Transactions (Details) [Line Items]
Aggregate purchase price of common stock			$ 634	$ 44,080
Revenue from contract with related parties	$ 426	$ 434	1,263	1,494
Accounts receivable related parties	4,092		4,092		$ 2,540
Amount received from related parties			843	$ 48
Subscription Notes Receivables [Member]
Related Party Transactions (Details) [Line Items]
Notes receivable from related parties	$ 0		$ 0
Subscription Notes Receivables [Member] | Minimum [Member]
Related Party Transactions (Details) [Line Items]
Accrued interest percentage	1.40%		1.40%
Subscription Notes Receivables [Member] | Maximum [Member]
Related Party Transactions (Details) [Line Items]
Accrued interest percentage	2.70%		2.70%

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Shareholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Earnings Per Share [Abstract]
Net loss	$ (162,949)	$ (12,454)	$ (195,616)	$ (43,157)
Denominator: Basic and Diluted Weighted-average shares in computing net loss per share attributable to common stockholders	87,178,432	65,067,942	74,001,217	64,064,424
Net loss attributable to common stockholders - basic and diluted	$ (1.87)	$ (0.19)	$ (2.64)	$ (0.67)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Shareholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	18,285,768	40,045,825
Shares of Common Stock Issuable from Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,474,840	2,671,317
Total RSUs Unvested Pending Settlement [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	8,204,455	16,102,029
Shares of Common Stock Issuable upon Conversion from Preferred Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		21,272,479
Private Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	10,200
Public Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	8,596,273

Net Loss Per Share Attributab_5

Net Loss Per Share Attributable to Common Shareholders (Additional Information) (Details) - shares	Aug. 26, 2021	Oct. 31, 2020
Private Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrants outstanding	5,200,000	0
Public Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrants outstanding	8,624,992	0

COVID-19 - CARES Act. provisi_2

COVID-19 - CARES Act. provision (Additional Information) (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 21, 2021	Apr. 21, 2021	Oct. 31, 2020
Unusual Risk or Uncertainty [Line Items]
Debt Instrument, Face Amount				$ 15,000
CARES Act [Member] | Impact Of PPP Loan Under CARES Act [Member] | Other Current And Long Term Liabilities [Member]
Unusual Risk or Uncertainty [Line Items]
Deferred Payroll Tax Amount	$ 1,378
CARES Act [Member] | Impact Of PPP Loan Under CARES Act [Member] | Due On December Thirty One Two Thousand Twenty One [Member]
Unusual Risk or Uncertainty [Line Items]
Percentage Of Deferred Payroll Taxes Amount Due Next Twelve Months			50.00%
CARES Act [Member] | Impact Of PPP Loan Under CARES Act [Member] | Due On December Thirty One Two Thousand Twenty Two [Member]
Unusual Risk or Uncertainty [Line Items]
Percentage Of Deferred Payroll Taxes Amount Due Year One		50.00%
CARES Act [Member] | Payback Protection Program Loan [Member]
Unusual Risk or Uncertainty [Line Items]
Debt Instrument, Face Amount					$ 5,580
Debt Instrument, Frequency of Periodic Payment	monthly
Debt Instrument, Date of First Required Payment	Sep. 15, 2021
Debt Instrument, Interest Rate, Stated Percentage	1.00%
Interest Expense Accrual On Debt	$ 0					$ 44

Retirement Plans (Additional In

Retirement Plans (Additional Information) (Details)	9 Months Ended
	Oct. 31, 2021
Retirement Benefits [Abstract]
Employee contribution matching percentage	4.00%

Subsequent Events (Additional I

Subsequent Events (Additional Information) (Details)	Nov. 23, 2021shares
2021 Equity Incentive Plan [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
RSU Grant	1,149,605